Funder
U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health
American Heart Association
Neven-DuMont Foundation
Deutsche Forschungsgemeinschaft
Publisher
Springer Science and Business Media LLC
Subject
Immunology,Immunology and Allergy
Reference56 articles.
1. Tse, K. et al. Atheroprotective vaccination with MHC-II restricted peptides from ApoB-100. Front. Immunol. 4, 493 (2013).
2. Kimura, T. et al. Atheroprotective vaccination with MHC-II-restricted ApoB peptides induces peritoneal IL-10-producing CD4 T cells. Am. J. Physiol. 312, H781–H790 (2017).
3. Kimura, T. et al. Regulatory CD4+ T cells recognize major histocompatibility complex class II molecule-restricted peptide epitopes of apolipoprotein B. Circulation 138, 1130–1143 (2018).
4. Wolf, D. et al. Pathogenic autoimmunity in atherosclerosis evolves from initially protective apolipoprotein B 100 –reactive CD4+ T-regulatory cells. Circulation 142, 1279–1293 (2020).
5. Marchini, T., Hansen, S. & Wolf, D. ApoB-specific CD4+ T cells in mouse and human atherosclerosis. Cells 10, 446 (2021).
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献